Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
Current Value
$12.011 Year Return
Current Value
$12.011 Year Return
Market Cap
$1.58B
P/E Ratio
92.17
1Y Stock Return
-11.37%
1Y Revenue Growth
-27.79%
Dividend Yield
0.00%
Price to Book
2.3
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PRTA | 44.40% | $756.01M | -56.52% | 0.00% |
HALO | 38.22% | $5.70B | +15.25% | 0.00% |
ADEA | 36.76% | $1.20B | +17.45% | 1.74% |
ALEC | 36.07% | $377.04M | -19.46% | 0.00% |
KRNT | 34.78% | $1.48B | +73.34% | 0.00% |
PSTX | 34.65% | $269.98M | +6.13% | 0.00% |
VIR | 34.17% | $954.40M | -26.51% | 0.00% |
SUPN | 34.10% | $1.96B | +30.48% | 0.00% |
PACB | 33.98% | $471.05M | -79.23% | 0.00% |
G | 33.68% | $7.83B | +31.86% | 1.34% |
ARCT | 33.28% | $489.20M | -21.27% | 0.00% |
KFRC | 33.12% | $1.10B | -8.71% | 0.66% |
VRDN | 32.86% | $1.60B | +28.92% | 0.00% |
AXON | 32.25% | $46.53B | +167.14% | 0.00% |
TASK | 32.02% | $1.27B | +16.72% | 0.00% |
SDGR | 31.78% | $1.38B | -35.46% | 0.00% |
HCKT | 31.76% | $838.57M | +36.65% | 1.45% |
OSUR | 31.71% | $287.93M | -46.24% | 0.00% |
EXEL | 31.64% | $9.83B | +62.16% | 0.00% |
KN | 31.64% | $1.60B | +12.19% | 0.00% |
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
We recently compiled a list of the 10 Best Small-Cap Stocks Ready To Explode. In this article, we are going to take a look at where Dynavax Technologies Corporation (NASDAQ:DVAX) stands against the other small-cap stocks. Prospects For Extended Outperformance Of Small-Cap Stocks On October 7, Chuck Royce, founder and Senior Advisor, and Francis Gannon, Co-Chief […]
SeekingAlpha
Dynavax Technologies Corporation's flagship product, Heplisav-B, continues to increase market share consistently in a growing market. Click for this DVAX update.
Finnhub
Item 8.01. Other Events On November 8, 2024, Dynavax Technologies Corporation entered into an...
Yahoo
The consensus price target hints at an 88.3% upside potential for Dynavax Technologies (DVAX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Yahoo
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that it has entered into an Accelerated Share Repurchase transaction ("ASR") under an agreement with Goldman Sachs & Co. LLC to repurchase $100 million of the Company's common stock. Dynavax executed the ASR as part of the $200 million share repurchase program authorized by its Board of Directors in November 2024. Upon completion of thi
Yahoo
Shareholders of Dynavax Technologies Corporation ( NASDAQ:DVAX ) will be pleased this week, given that the stock price...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRIS | -0.03% | $32.09M | -55.52% | 0.00% |
APRE | 0.03% | $16.41M | -19.47% | 0.00% |
NNE | 0.05% | $833.66M | +531.50% | 0.00% |
WMT | -0.06% | $696.11B | +66.69% | 1.38% |
WEST | 0.07% | $640.48M | -20.75% | 0.00% |
FATBB | -0.10% | $81.94M | -12.91% | 11.69% |
SKX | 0.11% | $9.15B | +11.11% | 0.00% |
RWAY | 0.12% | $394.72M | -17.18% | 15.47% |
AMED | 0.13% | $2.95B | -3.95% | 0.00% |
PENG | 0.15% | $911.79M | +4.97% | 0.00% |
HIHO | 0.18% | $8.63M | 0.00% | 6.12% |
LU | -0.19% | $2.01B | -33.75% | 0.00% |
QURE | 0.22% | $283.68M | -13.52% | 0.00% |
CLLS | 0.22% | $141.30M | -30.99% | 0.00% |
WLKP | -0.23% | $796.39M | +4.00% | 8.34% |
AVGO | 0.23% | $772.28B | +68.52% | 9.87% |
MBI | 0.25% | $335.78M | +105.79% | 0.00% |
PDD | 0.27% | $163.43B | +0.29% | 0.00% |
IMXI | -0.27% | $651.21M | -1.55% | 0.00% |
LVO | 0.29% | $73.65M | -26.68% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PSEC | -17.29% | - | - | 15.48% |
SMCI | -13.21% | $16.55B | -2.47% | 0.00% |
PLG | -11.72% | $173.19M | +67.33% | 0.00% |
WM | -10.86% | $87.92B | +27.58% | 1.34% |
TEM | -9.82% | $8.50B | 0.00% | 0.00% |
TCTM | -9.24% | $8.10M | -42.99% | 0.00% |
CYCN | -9.16% | $4.77M | -16.19% | 0.00% |
VZIO | -9.00% | $2.29B | +67.76% | 0.00% |
SCCO | -8.66% | $82.03B | +39.48% | 2.02% |
CYD | -8.40% | $364.46M | -2.94% | 4.26% |
AZO | -7.86% | $52.52B | +16.10% | 0.00% |
HE | -7.41% | $1.82B | -17.47% | 0.00% |
YY | -7.04% | $1.47B | -12.63% | 0.00% |
AGS | -6.93% | $479.25M | +57.18% | 0.00% |
DG | -6.77% | $16.82B | -37.95% | 3.17% |
BVN | -6.68% | $3.16B | +37.49% | 0.00% |
PULM | -6.61% | $19.83M | +202.98% | 0.00% |
STG | -6.54% | $35.67M | +7.92% | 0.00% |
HBM | -6.43% | $3.19B | +100.00% | 0.16% |
GFI | -6.36% | $13.42B | +10.06% | 2.63% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -26.69% | $195.31M | 0.85% |
BTAL | -22.78% | $388.04M | 1.43% |
TAIL | -14.63% | $67.98M | 0.59% |
TPMN | -12.25% | $40.60M | 0.65% |
MSOS | -10.82% | $632.80M | 0.83% |
DBO | -10.41% | $217.57M | 0.77% |
CSHI | -10.22% | $482.85M | 0.38% |
DBE | -10.02% | $50.13M | 0.77% |
CPER | -9.37% | $159.52M | 0.97% |
COMT | -9.24% | $829.06M | 0.48% |
KMLM | -8.96% | $353.87M | 0.9% |
DBB | -8.93% | $126.37M | 0.77% |
CTA | -8.81% | $350.27M | 0.78% |
PHDG | -8.25% | $113.97M | 0.39% |
GSG | -7.96% | $914.42M | 0.75% |
DBC | -7.93% | $1.39B | 0.87% |
MUST | -7.27% | $410.00M | 0.23% |
GCC | -6.85% | $133.23M | 0.55% |
BILZ | -6.18% | $563.02M | 0.14% |
UUP | -6.07% | $309.25M | 0.77% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
JUCY | -0.06% | $324.29M | 0.6% |
HYMB | 0.21% | $2.81B | 0.35% |
KCCA | 0.36% | $220.51M | 0.87% |
FMF | -0.37% | $244.61M | 0.95% |
FLMI | 0.40% | $356.19M | 0.3% |
IBMM | 0.42% | $391.28M | 0.18% |
FBY | -0.51% | $127.69M | 0.99% |
DUSB | 1.13% | $797.63M | 0.15% |
TBIL | -1.27% | $4.38B | 0.15% |
HIGH | -1.42% | $302.78M | 0.51% |
DFNM | 1.48% | $1.40B | 0.17% |
AGZD | 1.87% | $142.76M | 0.23% |
GBIL | -1.87% | $5.60B | 0.12% |
XBIL | 2.01% | $637.70M | 0.15% |
CLOI | -2.14% | $715.40M | 0.4% |
HYD | 2.62% | $3.18B | 0.32% |
SHYD | 2.66% | $311.50M | 0.35% |
BOXX | 2.74% | $4.43B | 0.1949% |
MUNI | 2.78% | $1.73B | 0.35% |
PDBC | 3.22% | $4.40B | 0.59% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PBE | 46.31% | $258.53M | 0.58% |
ARKG | 40.39% | $1.13B | 0.75% |
XBI | 40.30% | $6.58B | 0.35% |
XPH | 39.93% | $157.87M | 0.35% |
IBB | 39.84% | $6.66B | 0.45% |
FBT | 39.79% | $1.11B | 0.56% |
SMMV | 38.00% | $321.07M | 0.2% |
IWC | 37.18% | $933.99M | 0.6% |
GNOM | 36.95% | $70.59M | 0.5% |
BBH | 36.25% | $397.87M | 0.35% |
XAR | 34.20% | $2.56B | 0.35% |
PTH | 34.18% | $143.31M | 0.6% |
FXH | 33.66% | $1.15B | 0.62% |
GSSC | 33.34% | $529.86M | 0.2% |
VTWO | 33.27% | $12.38B | 0.1% |
IWM | 33.17% | $75.73B | 0.19% |
EES | 32.87% | $668.71M | 0.38% |
FYX | 32.87% | $959.00M | 0.6% |
XSLV | 32.76% | $322.27M | 0.25% |
IWO | 32.69% | $12.56B | 0.24% |